Bristol Myers Squibb (BMY) Amortization - Intangibles (2019 - 2026)

Bristol Myers Squibb (BMY) has 8 years of Amortization - Intangibles data on file, last reported at $437.0 million in Q1 2026.

• Amortization - Intangibles for Q1 2026 came in at $437.0 million, down 47.35% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.9 billion (down 60.19% YoY), and the FY2025 annual result was $3.3 billion, down 62.61% from the prior year.
• Amortization - Intangibles eased to $437.0 million in Q1 2026 per BMY's latest filing, from $826.0 million in the prior quarter.
• Over five years, Amortization - Intangibles peaked at $2.4 billion in Q3 2022 and troughed at $437.0 million in Q1 2026.
• A 5-year average of $1.8 billion and a median of $2.3 billion in 2023 frame the typical range for Amortization - Intangibles.
• The sharpest annual moves came in 2024 and 2025: Amortization - Intangibles rose 7.04% in 2024, then slumped 65.65% in 2025.
• A 5-year view of Amortization - Intangibles shows it stood at $2.3 billion in 2022, then dropped by 2.77% to $2.3 billion in 2023, then slipped by 25.68% to $1.7 billion in 2024, then plunged by 51.21% to $826.0 million in 2025, then plunged by 47.09% to $437.0 million in 2026.
• Business Quant data shows BMY's Amortization - Intangibles at $437.0 million in Q1 2026, $826.0 million in Q4 2025, and $831.0 million in Q3 2025.